Belviq Lawsuit

Weight-loss drugs are not known for their safety; unfortunately, Belviq is no exception. In a five-year, double-blind study of 12,000 patients, those taking Belviq were more likely to be diagnosed with cancer than those taking a placebo (sugar pill). The FDA stated, “A range of cancer types was reported, with several different types of cancers occurring more frequently in the lorcaserin group,” including:

• Pancreatic cancer
• Colorectal cancer
• Lung cancer

This is a drug that probably should never have been on the market, and the manufacturers need to be held accountable. Those suffering from cancer caused by Belviq deserve compensation.

Yes. In February 2020, the FDA requested that manufacturer Eisai pull all Belviq and Belviq XR products from the market. Eisai has complied with the request.

Anyone taking Belviq should stop and talk to a healthcare professional about possible safer alternatives.

If you took Belviq or its generic equivalent and were diagnosed with cancer, you should consider taking legal action against the drug’s manufacturer. If you meet these criteria, you may have a case:

• Over the age of 18
• Diagnosed with cancer after taking Belviq, Belviq XR, or another brand of lorcaserin
• If a loved one took this weight loss drug and was diagnosed with cancer, you may also contact us on their behalf

Every case is unique, but people who successfully file drug or medical device lawsuits can recover compensation for some or all of the following damages:

• Past and future medical bills (including medication, hospital stays, and in-home care)
• Pain and suffering
• Lost wages
• Loss of earning capacity
• Funeral expenses (in the event of a loved one’s death)
• Broadly speaking, a plaintiff may be entitled to compensation for any past and future costs associated with their cancer diagnosis